Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor

Therapie

Volumn 69, Issue 3, 2014, Pages 245-247

  Hamza, Imene ^a   Gaies, Emna ^a,b   Kastalli, Sarrah ^a,b   Daghfous, Riadh ^a,b   El Aidli, Sihem ^a,b  

^a Centre National de Pharmacovigilance   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Gastrointestinal stromal tumor; Hyperpigmentation; Imatinib; Plasma monitoring

Indexed keywords

IMATINIB;

ARTICLE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HYPERPIGMENTATION; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BENZAMIDES; FACIAL DERMATOSES; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; HYPERPIGMENTATION; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 84904294770     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2014018     Document Type: Letter

References (26)

1. Hochhaus A. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST). Ann Hematol 2004; 83: S65-6
2. Wong DW, Lupton SC, Bhatt L et al,. Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience. Clin Oncol 2008; 20: 517-22
3. Mauro MJ, O'Dwyer M, Heinrich MC et al,. STI571: a paradigm of new agents for cancer therapeutics. J Clin Oncol 2002; 20: 325-34
4. Guilhot F. Indications for imatinib mesylate therapy and clinical management. Oncologist 2004; 9: 271-81
5. O'Brien SG, Guilhot F, Larson RA et al,. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994-1004
6. Arora B, Kumar L, Sharma A et al,. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate. Ann Oncol 2004; 15: 358-9
7. st, 2013
8. Alexandrescu DT, Dasanu CA, Farzanmehr H et al., Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatol Online J 2008; 14 (7): 7
9. Bouchet S, Royer B, Le Guellec C et al,. Niveau de preuve du suivi thérapeutique pharmacologique des inhibiteurs de tyrosine-kinase dans le traitement des leucémies myéloïdes chroniques. Therapie 2010; 65: 213-8
10. Wiper A, Roberts DH, Schmitt M. Amiodarone-induced skin pigmentation: Q-switched laser therapy, an effective treatment option. Heart 2007; 93 (1): 15
11. Dereure O. Drug-induced skin pigmentation: epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2: 253-62
12. Gupta LK, Tanwar RK, Khare AK et al,. Bleomycin induced flagellate pigmentation. Indian J Dermatol Venereol Leprol 2002; 68: 158-9
13. Holm AN, Nelson WK. Images in clinical medicine. Minocycline-induced hyperpigmentation. N Engl J Med 2006; 355: e23
14. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2: 253-62
15. Arimone Y, Bidault I, Dutertre JP et al,. Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments. Therapie 2011; 66: 517-25
16. st, 2013
17. Resende RG, Teixeira RG, Vasconcelos Fde O et al,. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient. J Craniomaxillofac Surg 2012; 40: e140-3
18. Li CC, Malik SM, Blaeser BF et al,. Mucosal pigmentation caused by imatinib: report of three cases. Head and Neck Pathol 2012; 6: 290-95
19. Lewis DM. Diffuse pigmentation of the palate. J Okla Dent Assoc 2009; 100: 24-5
20. Mattsson U, Halbritter S, Mörner Serikoff E et al,. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: e12-6
21. Singh N, Bakhshi S. Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia. J Pediatr Hematol Oncol 2007; 29: 208-9
22. Mcpherson T, Sherman V, Turner R. Imatinib-associated hyperpigmentation, a side effect that should be recognized. JEADV 2009; 23: 82-3
23. Etienne G, Cony-Makhoul P, Mahon FX. Imatinib mesylate and gray hair. N Engl J Med 2002; 347 (6): 446
24. Maeyama H, Hidaka E, Ota H et al,. Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germlinemutation of the c-kit gene. Gastroenterology 2001; 120: 210-5
25. Lammie A, Drobnjak M, Gerald W et al,. Expression of c-kit and kit ligands proteins in normal human tissues. J Histochem Cytochem 1994; 42: 1417-25
26. Wu M, Hemesath TJ, Takemoto CM. C-kit triggers dual phosphorylations wich couple activation and degradation of the essentiel melanocyte factor Mi. Genes Dev 2000; 14 (3): 301-12